Vertex faces pressure from potential U.S. drug pricing reforms and tariffs. Click here to find out why VRTX stock is a Hold.

Vertex Pharmaceuticals Incorporated VRTX stock has declined 23.6% in the past six months, mainly due to recent pipeline ...

From shocking outliers to budget-friendly powerhouses, we've learned which cordless vacuums truly excel in battery life, ...

The Railway Protection Force (RPF) has officially released the zone-wise vacancy details for the post of Sub Inspector (Executive) under recruitment notification CEN RPF-01/2024. A total of 452 ...

Ratings for Vertex Pharmaceuticals (NASDAQ: VRTX) were provided by 15 analysts in the past three months, showcasing a mix of ...

Vertex's revenue was $2.96 billion in the second quarter of 2025, beating the consensus forecast by $58 million. Click here ...

Vertex Pharmaceuticals is offering Enlaza Therapeutics more than $2 billion in biobucks through a multitarget drug discovery deal aiming to create new T-cell engagers and small-format drug conjugates.

Triglycerides function differently because they represent blood fat, which serves as an energy reserve from dietary excess calories. The body uses triglycerides stored in fat cells for energy supply, ...

Enlaza Therapeutics Inc. will take charge of research through nominating candidates in its potentially $2 billion-plus deal with Vertex Pharmaceuticals Inc. For its efforts, Enlaza is getting $45 ...

At this grand event focusing on the deep integration of technology and innovation, Xu Yihan, Senior Executive Vice President ...